Ringelstein EB - Search Results

1

Growth inhibition of newly established human glioma cell lines by leukemia inhibitory factor.

Halfter H, Kremerskothen J, Weber J, Hacker-Klom U, Barnekow A, Ringelstein EB, Stögbauer F. Halfter H, et al. Among authors: ringelstein eb. J Neurooncol. 1998 Aug;39(1):1-18. doi: 10.1023/a:1005901423332. J Neurooncol. 1998. PMID: 9760066

2

Inhibition of growth and induction of differentiation of glioma cell lines by oncostatin M (OSM).

Halfter H, Lotfi R, Westermann R, Young P, Ringelstein EB, Stögbauer FT. Halfter H, et al. Among authors: ringelstein eb. Growth Factors. 1998;15(2):135-47. doi: 10.3109/08977199809117189. Growth Factors. 1998. PMID: 9505169

3

Activation of Jak-Stat and MAPK2 pathways by oncostatin M leads to growth inhibition of human glioma cells.

Halfter H, Friedrich M, Postert C, Ringelstein EB, Stögbauer F. Halfter H, et al. Among authors: ringelstein eb. Mol Cell Biol Res Commun. 1999 May;1(2):109-16. doi: 10.1006/mcbr.1999.0117. Mol Cell Biol Res Commun. 1999. PMID: 10356359

4

CNTF and its receptor subunits in human gliomas.

Weis J, Schönrock LM, Züchner SL, Lie DC, Sure U, Schul C, Stögbauer F, Ringelstein EB, Halfter H. Weis J, et al. Among authors: ringelstein eb. J Neurooncol. 1999;44(3):243-53. doi: 10.1023/a:1006303221064. J Neurooncol. 1999. PMID: 10720204

5

Oncostatin M-mediated growth inhibition of human glioblastoma cells does not depend on stat3 or on mitogen-activated protein kinase activation.

Halfter H, Stögbauer F, Friedrich M, Serve S, Serve H, Ringelstein EB. Halfter H, et al. Among authors: ringelstein eb. J Neurochem. 2000 Sep;75(3):973-81. doi: 10.1046/j.1471-4159.2000.0750973.x. J Neurochem. 2000. PMID: 10936178 Free article.

6

Activation of the Jak-Stat- and MAPK-pathways by oncostatin M is not sufficient to cause growth inhibition of human glioma cells.

Halfter H, Postert C, Friedrich M, Ringelstein EB, Stögbauer F. Halfter H, et al. Among authors: ringelstein eb. Brain Res Mol Brain Res. 2000 Sep 15;80(2):198-206. doi: 10.1016/s0169-328x(00)00162-5. Brain Res Mol Brain Res. 2000. PMID: 11038252

7

Complete inhibition of in vivo glioma growth by oncostatin M.

Friedrich M, Höss N, Stögbauer F, Senner V, Paulus W, Ringelstein EB, Halfter H. Friedrich M, et al. Among authors: ringelstein eb. J Neurochem. 2001 Mar;76(5):1589-92. doi: 10.1046/j.1471-4159.2001.00202.x. J Neurochem. 2001. PMID: 11238743 Free article.

8

[Molecular biology and genetics of hereditary motor and sensory neuropathies].

Stögbauer F, Halfter H, Young P, Ringelstein EB. Stögbauer F, et al. Among authors: ringelstein eb. Nervenarzt. 1996 Dec;67(12):987-97. doi: 10.1007/s001150050081. Nervenarzt. 1996. PMID: 9082200 Review. German.

9

Kinetics of 3-[(123)I]iodo-l-alpha-methyltyrosine transport in rat C6 glioma cells.

Riemann B, Stögbauer F, Kopka K, Halfter H, Lasic M, Schirmacher A, Kuwert T, Weckesser M, Ringelstein EB, Schober O. Riemann B, et al. Among authors: ringelstein eb. Eur J Nucl Med. 1999 Oct;26(10):1274-8. doi: 10.1007/pl00006652. Eur J Nucl Med. 1999. PMID: 10541825

10

Kinetic parameters of 3-[(123)I]iodo-L-alpha-methyl tyrosine ([(123)I]IMT) transport in human GOS3 glioma cells.

Riemann B, Kopka K, Stögbauer F, Halfter H, Ketteler S, Phan TQ, Franzius C, Weckesser M, Ringelstein EB, Schober O. Riemann B, et al. Among authors: ringelstein eb. Nucl Med Biol. 2001 Apr;28(3):293-7. doi: 10.1016/s0969-8051(01)00191-3. Nucl Med Biol. 2001. PMID: 11323240

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

511 results

Search Page

Filters